Glucose Transporters in Brain: In Health and in Alzheimer's Disease

Journal of Alzheimer's Disease

Volumn 55, Issue 4, 2017, Pages 1307-1320

  Szablewski, Leszek ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Alzheimer's disease; brain; compensatory mechanisms; GLUT proteins; SGLT proteins

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; GLUCOSE TRANSPORTER; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3; SODIUM GLUCOSE COTRANSPORTER; N ACETYLGLUCOSAMINYLTRANSFERASE; O-GLCNAC TRANSFERASE; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN; BRAIN CORTEX; ENERGY; GLUCOSE METABOLISM; HUMAN; HUNTINGTON CHOREA; INSULIN RESISTANCE; NERVE DEGENERATION; PRIORITY JOURNAL; REVIEW; ACETYLATION; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY;

ACETYLATION; ALZHEIMER DISEASE; ANIMALS; BRAIN; GENE EXPRESSION REGULATION; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; N-ACETYLGLUCOSAMINYLTRANSFERASES; PHOSPHORYLATION; TAU PROTEINS;

EID: 85007168688     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-160841     Document Type: Review

References (165)

1. Welcome MO, Pereverzeva EV, Pereverzev VA (2011) Long-term disorders of cognitive functions in sober people who episodically use alcohol, role of functional hypoglycemia and insufficiency of gluconeogenesis. Vestnik Smolensk Med Acad 3, 2-20.
2. Welcome MO, Razvodovsky YE, Pereverzeva EV, Pereverzev VA (2013) State of cognitive functions of student-medics with different relationship to alcohol use. Belarusian State Medical University Press, Minsk, Belarus, pp. 5-160.
3. Welcome MO, Pereverzev VA (2014) Glycemia and memory. In Glucose Homeostasis, Szablewski L, ed. In Tech, Croatia, pp. 113-130.
4. Magistretti PJ, Pellerin L (1999) Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging. Philos Trans R Soc Lond B 254, 1155-1163.
5. Larrabee MG (1995) Lactate metabolism and its effect on glucose metabolism in an exercised neural tissue. J Neurochem 64, 1734-1741.
6. Magistretti PJ, Pellerin L (1999) Astrocytes couple synaptic activity to glucose utilization in the brain. News Physiol Sci 14, 177-182.
7. Tekkok SB, Brown AM, Westenbroek R, Pellerin L, Ransom BR (2005) Transfer of glycogen-derived lactate from astrocytes to axons via specific monocarboxylate transporters supports mouse optic nerve activity. J Neurosci Rev 81, 644-652.
8. Goldstein GW (1979) Relation of potassium transport to oxidative metabolism in isolated brain capillaries. J Physiol 286, 185-195.
9. Guzman M, Blazquez C (2001) Is there an astrocyteneuron ketone body shuttle? Trends Endocrinol Metab 12, 169-173.
10. Pardridge WM (1991) Blood-brain barrier transport of glucose, free fatty acids, and ketone bodies. Adv Exp Med Biol 291, 43-53.
11. Cunnane S, Nugent S, Roy M, Courchesne-Loyer A, Croteau E, Tremblay S, Castellano A, Pifferi F, Bocti C, Paquet N, Begdouri H, Bentourkia M, Turcotte E, Allard M, Barberger-Gateau P, Fulop T, Rapoport SI (2011) Brain fuel metabolism, aging, and Alzheimer's disease. Nutrition 27, 3-20.
12. Liu Y, Liu F, Iqbal K, Grundke-Iqbal I, Gang C-X (2008) Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett 582, 359-364.
13. McClory H, Williams D, Sapp E, Gatune LW, Wang P, Di Figlia M, Li X (2014) Glucose transporter 3 is a rab 11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington's disease mice. Acta Neuropathol Commun 2, 179.
14. Besson MT, Alegria K, Garrido-Gerter P, Barros LF, Liévens J-C (2015) Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila model. PLoS One 10, e0118765.
15. Kovitz CA, Morgello S (1997) Cerebral glucose transporter expression in HIV infection. Acta Neuropathol 94, 140-145.
16. Mullen SA, Marini C, Suls A, Mei D, Giustina ED, Buti D, Arsov T, Damiano J, Lawrence K, De Jonghe P, Berkovic SF, Scheffer IE, Guerrini R (2011) Glucose transporter deficiency as a treatable cause of myoclonic astatic epilepsy. Arch Neurol 68, 1152-1155.
17. Shah K, De Silva S, Abbruscato T (2012) The role of glucose transporters in brain disease: Diabetes and Alzheimer's disease. Int J Mol Sci 13, 12629-12655.
18. Maurer MH, Geomor HK, Bürgers HF, Schelshorn DW, Kuschinsky W (2006) Adult neural stem cells express glucose transporters GLUT1 and GLUT3 and regulate GLUT3 expression. FEBS Lett 580, 4430-4434.
19. Bruckner BA, Ammini CV, Otal MP, Raizada MK, Stacpoole PW (1999) Regulation of brain glucose transporters by glucose and oxygen deprivation. Metabolism 48, 422-431.
20. Mukherji S, Jacobson A (2014) Effects of glucose on the brain [internet]. Diapedia 61047161570 rev. no. 6. Available from: http://dx.doi.org/10.14496/dia. 61047161570.6
21. Augustin R, Mayoux E (2014) Mammalian sugar transporters. In Glucose Homeostasis, Szablewski Led. In Tech, Croatia, pp. 3-36.
22. Vannucci SJ, Maher F, Simpson IA (1997) Glucose transporter proteins in brain: Delivery of glucose to neurons and glia. Glia 21, 2-21.
23. Vorbrodt AW, Dobrogowska DH, Tarnawski M (2001) Immunogold study of interendothelial junction-associated and glucose transporter proteins during postnatal maturation of mouse blood-brain barrier. J Neurocytol 30, 705-716.
24. McEwen BS, Reagan LP (2004) Glucose transporter expression in the central nervous system: Relationship to synaptic function. Eur J Pharmacol 490, 13-24.
25. Simpson IA, Dwyer D, Malide D, Moley KH, Travis A, Vannucci SJ (2008) The facilitative glucose transporter GLUT3:20 years of distinction. Am J Physiol Endocrinol Metab 295, E242-E253.
26. Alafuzoff I, Iqbal K, Friden H, Adolfsson R, Wimblad B (1987) Histopathological criteria for progressive dementia disorders: Clinical-pathological correlation and classification by multivariate data analysis. Acta Neuropathol (Berl) 74, 209-225.
27. Hoyer S (2002) The brain insulin signal transduction system and sporadic (type II) Alzheimer disease: An update. J Neural Transm 109, 341-360.
28. Pujol-Gimenez J, Martisova E, Perez-Mediavilla A, Lostao MP, Ramirez MJ (2014) Expression of glucose transporter GLUT12 in Alzheimer's disease patients. J Alzheimers Dis 42, 97-101.
29. Hoyer S (1992) Oxidative energy metabolism in Alzheimer brain. Studies in early-onset and late-onset cases. Mol Chem Neuropathol 16, 207-224.
30. Jagust WJ, Seab JP, Huesman RH, Valk PE, Mathis CA, Reed BR, Coxson PG, Budinger TF (1991) Diminished glucose transport in Alzheimer's disease: Dynamic PET studies. J Cereb Blood Flow Metab 11, 323-330.
31. Piert M, Koeppe RA, Giordani B, Berent S, Kuhl DE (1996) Diminished glucose transport and phosphorylation in Alzheimer's disease determined by dynamic FDG-PET. J Nucl Med 37, 201-208.
32. Friedland RP, Jagust WJ, Huesman RH, Koss E, Knittel B, Mathis CA, Ober BA, Mazoyer BM, Budinger TF (1989) Regional cerebral glucose transport and utilization in Alzheimer's disease. Neurology 39, 1427-1434.
33. Simpson IA, Davies P (1994) Reduced glucose transporter concentrations in brains of patients with Alzheimer's disease. Ann Neurol 36, 800-801.
34. Harik SI (1992) Changes in the glucose transporter of brain capillaries. Can J Physiol Pharmacol 70(Suppl.), S113-S117.
35. Kalaria RN, Harik SI (1989) Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer's disease. J Neurochem 53, 1083-1088.
36. Liu F, Shi J, Tanimukai H, Gu J, Gu J, Grundke-Iqbal I, Iqbal K, Gong CX (2009) Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 132, 1820-1832.
37. Hooijmans CR, Graven C, Dederen PJ, Tanila H, van Groen T, Kiliaan AJ (2007) Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res 1181, 93-103.
38. Šalković-Petrišić M, Riederer P (2010) Brain glucose transporter protein 2 and sporadic Alzheimer's disease. Trans Neurosci 1, 200-206.
39. Huang Y, Lei L, Liu D, Jovin I, Russell R, Johnson RS, Di Lorenzo A, Giordano FJ (2012) Normal glucose uptake in the brain and heart requires an endothelial cell-specific HIF-1α-dependent function. Proc Natl Acad Sci U S A 109, 17478-17483.
40. Havrankova J, Roth J, Brownstein M (1978) Insulin receptors are widely distributed in the central nervous system of the rat. Nature 272, 827-829.
41. Liu Y, Liu F, Grundke-Iqbal I, Iqbal K, Gong CX (2011) Deficient brain insulin signaling pathway in Alzheimer's disease and diabetes. J Pathol 225, 54-62.
42. Vannucci SJ, Koehler-Stec EM, Li K, Reynolds TH, Clark R, Simpson IA (1998) GLUT4 glucose transporter expression in rodent brain: Effect of diabetes. Brain Res 797, 1-11.
43. Lester-Coll N, Rivera EJ, Soscia SJ, Doiron K, Wands JR, de la Monte SM (2006) Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer's disease. J Alzheimers Dis 9, 13-33.
44. Šalković-Petrišić M, Osmanović J, Grünblatt E, Riederer P, Hoyer S (2009) Modeling sporadic Alzheimer's disease: The insulin resistant brain state generates multiple long-term morphobiological abnormalities inducing hyperphosphorylated tau protein and amyloid beta. J Alzheimers Dis 18, 729-750.
45. Heidenreich KA, Gilmore PR, Garvey WT (1989) Glucose transport in primary cultured neurons. J Neurosci Res 22, 397-407.
46. Uemura E, Greenlee HW (2001) Amyloid β-peptide inhibits neuronal glucose uptake by preventing exocytosis. Exp Neurol 170, 270-276.
47. Uemura E, Greenlee HW (2006) Insulin regulates neuronal glucose uptake by promoting translocation of glucose transporter GLUT3. Exp Neurol 198, 48-53.
48. Hoyer S, Nitsch R (1989) Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type. J Neural Transm 75, 227-232.
49. Pettegrew JW, Klunk WE, Kanal E, Panchalingam K, McClure RJ (1995) Changes in brain membrane phospholipid and high-energy phosphate metabolism precede dementia. Neurobiol Aging 16, 973-975.
50. Hoyer S, Nitsch R, Oesterreich K (1990) Ammonia is endogenously generated in the brain in the presence of presumed and verified dementia of Alzheimer type. Neurosci Lett 117, 358-362.
51. Simpson IA, Chundu KR, Davies-Hill T, Honer WG, Davies P (1994) Decreased concentrations of glut1 and glut3 glucose transporters in the brain of patients with Alzheimer's disease. Ann Neurol 35, 546-551.
52. Qutub AA, Hunt CA (2005) Glucose transport to the brain: A system model. Brain Res Brain Res Rev 49, 595-617.
53. Farrell CL, Yang J, Pardridge WM (1992) GLUT-1 glucose transporter is present within apical and basolateral membranes of brain epithelial interfaces and in microvascular endothelia with and without tight junctions. J Histochem Cytochem 40, 193-199.
54. Piroli GG, Grillo CA, Hoskin EK, Znamensky V, Katz EB, Milner T, McEwen BS, Charron MJ, Reagan LP (2002) Peripheral glucose administration stimulates the translocation of GLUT 8 glucose transporter to the endoplasmic reticulum in the rat hippocampus. J Comp Neurol 452, 103-114.
55. Sankar R, Thamotharan S, Shin D, Moley KH, Devaskar SU (2002) Insulin-responsive glucose transporters - GLUT8 and GLUT4are expressed in the developing mammalian brain. Brain Res Mol Brain Res 107, 157-165.
56. Vemula S, Roderer K, Yang T, Bhat GJ, Thekkumkara TJ, Abbruscato TJ (2009) A functional role for sodiumdependent glucose transport across the blood-brain barrier during oxygen glucose deprivation. J Pharm Exp Therap 328, 487-495.
57. Yu S, Zhao T, Guo M, Fang H, Ma J, Ding A, Wang F, Chan P, Fan M (2008) Hypoxic preconditioning up-regulates glucose transport activity and glucose transporter (GLUT1 and GLUT3) gene expression after acute anoxic exposure in the cultured rat hippocampal neurons and astrocytes. Brain Res 1211, 22-99.
58. Dwyer DS, Vannucci SJ, Simpson IA (2002) Expression, regulation, and functional role of glucose transporters (GLUTs) in brain. Int Rev Neurobiol 51, 159-188.
59. Wright EM (2013) Glucose transport families SLC5 and SLC50. Mol Asp Med 34, 183-196.
60. Mueckler M, Thorens B (2013) The SLC2 (GLUT) family of membrane transporters. Mol Asp Med 34, 121-138.
61. Deng D, Yan N (2016) GLUT, SGLT, and SWEET: Structural and mechanistic investigations of the glucose transporters. Prot Sci 25, 546-558.
62. Dick AP, Harik SI, Klip A, Walker DM (1984) Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity. Proc Natl Acad Sci U S A 81, 7233-7237.
63. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201.
64. Zlokovic BV (2011) Naurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci 12, 723-738.
65. Maher F, Vannucci SJ, Simpson IA (1994) Glucose transporter proteins in brain. FASEB J 8, 1003-1011.
66. Vanucci SJ (1994) Developmental expression of GLUT1 and GLUT3 glucose transporters in rat brain. J Neurochem 62, 240-246.
67. De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI (1991) Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 325, 703-709.
68. Weber YG, Storch A, Wattke TU, Brockmann K, Kempfle J, Maljevic S, Margari L, Kamm C, Schneider SA, Huber SM, Pekrun A, Roebling R, Seebohm G, Koka S, Lang C, Kraft E, Blazevic D, Salvo-Vargas A, Fauler M, Mottaghy FM, Münchau A, Edwards MJ, Presicci A, Margari F, Gasser T, Lang F, Bhatia KP, Lehmann-Horn F, Lerche H (2008) GLUT1 mutations are a cause of paroxymal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak. J Clin Invest 118, 2157-2168.
69. Rotstein M, Englelstad K, Yang H, Wang D, Levy B, Chun WK, De Vivo DC (2010) Glut 1 deficiency: Inheritance pattern determined by haploinsufficiency. Ann Neurol 68, 955-958.
70. Leloup C, Arluison M, Lepetit N, Cartier N, Marfaing-Jallat P, Ferré P, Pénicaud L (1994) Glucose transporter 2 (GLUT2): Expression in specific brain nuclei. Brain Res 638, 221-226.
71. Manolescu AR, Witkowska K, Kinnaird A, Cessford T, Cheeseman C (2007) Facilitated hexose transporters: New perspectives on form and function. Physiology 22, 234-240.
72. Garcia ML, Millan C, Balmaceda-Aguilera C, Castro T, Pastor P, Montecinos H, Reinicke K, Zúñiga F, Vera JC, Oñate SA, Nualart F (2003) Hypothalamic ependymalglial cells express the glucose transporter GLUT2, a protein involved in glucose sensing. J Neurochem 86, 709-724.
73. Young JK, McKenzie JC (2004) GLUT2 immunoreactivity in Gomori-positive astrocytes of the hypothalamus. J Histochem Cytochem 52, 1519-1524.
74. Kumari U, Heese K (2010) Cardiovascular dementia - A different perspective. The Open Biochem J 4, 29-52.
75. Arluison M, Quinon M, Thorens B, Leloup C, Pénicaud L (2004) Immunohistochemical localization of the glucose transporter 2 (GLUT2) in the adult rat brain. II Electron microscopic study. J Chem Neuroanat 28, 137-146.
76. Arluison M, Quinon M, Nguyen P, Thorens B, Leloup C, Pénicaud L (2004) Distribution and anatomical localization of the glucose transporter 2 (GLUT2) in the adult rat brain-an-immunohistochemical study. J Chem Neuroanat 28, 117-136.
77. Pénicaud L, Leloup C, Lorsignol A, Alquier T, Guillod E (2002) Brain glucose sensing mechanism and glucose homeostasis. Curr Opin Clin Nutr Metab Care 5, 539-543.
78. McCall AL, Van Buerer AM, Moholt-Siebert M, Cherry NJ, Woodward WR (1994) Immunohistochemical localization of the neuron-specific glucose transporter (GLUT3) to neuropil in adult rat brain. Brain Res 659, 292-297.
79. Gerhart DZ, Leino RL, Borson ND, Taylor WE, Gronlund KM, McCall AL, Drewes LR (1995) Localization of glucose transporter GLUT3 in brain: Comparison of rodent and dog using species-specific carboxyl-terminal antiser. Neuroscience 66, 237-246.
80. Choeiri C, Staines W, Messier C (2002) Immunohistochemical localization and quantification of glucose transporters in the mouse brain. Neuroscience 111, 19-34.
81. Nagamatsu S, Sawa H, Kamada K, Nakamichi Y, Yoshimoto K, Hoshino T (1993) Neuron-specific glucose transporter (NSGT): CNS distribution of GLUT3 rat glucose transporter (RGT3) in rat central neurons. FEBS Lett 334, 289-295.
82. Bondy CA, Lee W-H, Zhou J (1992) Ontogeny and cellular distribution of brain glucose transporter gene expressio. Mol Cell Neurosci 3, 305-314.
83. Piroli GG, Grillo CA, Reznikov LR, Adams S, McEwen BS, Charron MJ, Reagan LP (2007) Corticosterone impairs insulin-stimulated translocation of GLUT4 in the rat hippocampus. Neuroendocrinology 85, 71-80.
84. Leloup C, Arluison M, Kassis N, Lepetit N, Cartier N, Ferré P, Pénicaud L (1996) Discrete brain areas express the insulin-responsible glucose transporter GLUT4. Mol Brain Res 38, 45-53.
85. Kobayashi M, Nikami H, Morimatsu M, Saito M (1996) Expression and localization of insulin-regulatable glucose transporter (GLUT4) in rat brain. Neurosci Lett 213, 103-106.
86. Reagan LP (2002) Glucose, stress and hippocampal neurone vulnerability. Int Rev Neurobiol 51, 289-324.
87. El Messari S, Leloup C, Quignon M, Brisorqueil MJ, Penicaud L, Arluison M (1998) Immunocytochemical localization of the insulin-responsive glucose transporter 4 (Glut4) in the rat central nervous system. J Comp Neural 399, 492-512.
88. Vissing J, Andersen M, Diemer NH (1998) Exerciseinduced changes in local cerebral glucose utilization in the rat. J Cereb Blood Flow Metab 16, 729-736.
89. Alquier T, Leloup C, Lorsiqnol A, Pénicaud L (2006) Translocable glucose transporters in the brain. Where are we in 2006? Diabetes 55(Suppl 2), S131-S138.
90. Shepherd PR, Gibbs EM, Wesslau C, Gould GW, Kahn BB (1992) Human small intestine facilitative fructose/glucose transporter (GLUT5) is also present in insulin-responsive tissues and brain: Investigation of biochemical characteristics and translocation. Diabetes 41, 1360-1365.
91. Payne J, Maher F, Simpson I, Mattice L, Davies P (1997) Glucose transporter Glut5 expression in microglial cells. Glia 21, 327-331.
92. Nualart F, Godoy A, Reinicke K (1999) Expression of the hexose transporters GLUT1 and GLUT2 during the early development of the human brain. Brain Res 824, 97-104.
93. Mantych GJ, James DE, Devaskar SV (1993) Jejunal/kidney glucose transporter isoform (Glut-5) is expressed in human blood-brain barrier. Endocrinology 132, 35-40.
94. Funari VA, Herrera VL, Freeman D, Tolan DR (2005) Genes required for fructose metabolism are expressed in Purkinje cells in the cerebellum. Brain Res Mol Brain 142, 115-122.
95. Shu HJ, Isenberg K, Cormier RJ, Benz A, Zorumski CF (2006) Expression of fructose sensitive glucose transporter in the brain of fructose-fed rats. Neuroscience 140, 889-895.
96. Messier C, Whately K, Liang J, Du L, Puissant D (2007) The effects of a high-fat, high-fructose, and combination diet on learning, weight, and glucose regulation in C57BL/6 mice. Behav Brain Res 178, 139-145.
97. Hessel B, Elsais A, Frøland AS, Taubøll E, Gjerstad L, Quan L, Dingledine R, Rise F (2015) Uptake and metabolism of fructose by rat neocortical cells in vivo and by isolated nerve terminals in vitro. J Neurochem 133, 572-581.
98. Lisinski I, Schurmann A, Joost HG, Cushman SW, Al-Hasani H (2001) Targeting of GLUT6 (formely GLUT9) and GLUT8 in rat adipose cells. Biochem J 358, 517-522.
99. Reagan LP, Rosell DR, Alves SE, Hoskin EK, McCall AL, Charron MJ, McEwen BS (2002) GLUT8 glucose transporter is localized to excitatory and inhibitory neurons in the rat hippocampus. Brain Res 932, 129-134.
100. Ibberson M, Riederer BM, Uldry M, Guhl B, Roth J, Thorens B (2002) Immunolocalization of GLUTX1 in the testis and specific brain areas and vasopressin-containing neurons. Endocrinology 143, 276-284.
101. Coucke PJ, Willaert A, Wessels MW, Callewaert B, Zoppi N, De Backer J, Fox JE, Mancini GM, Kambouris M, Gardella R, Facchetti F, Willems PJ, Forsyth R, Dietz HC, Barlati S, Colombi M, Loeys B, De Paepe A (2006) Mutations in the facilitative glucose transporter GLUT10 alter angiogenesis and cause arterial tourtuosity syndrome. Nat Genet 38, 452-457.
102. Ho HTB, Dahlin A, Wang J (2012) Expression profiling of solute carrier gene families at the blood-CSF barrier. Front Pharmacol 3, 154.
103. Stuart CA, Howell ME, Zhang Y, Yin D (2009) Insulinstimulated translocation of glucose transporter (GLUT) 12 parallels that of GLUT4 in normal muscle. J Clin Endocr Metab 94, 3535-3542.
104. Flessner LB, Moley KH (2009) Similar [DE]XXXL[LI] motifs differentially target GLUT8 and GLUT12 in Chinese hamster ovary cells. Traffic 10, 324-333.
105. +/myoinositol symporter at synapses and growth cones. EMBO J 23, 531-540.
106. +/glucose cotransporters: From genes to therapy. Braz J Med Biol Res 43, 1019-1026.
107. +/glucose transport in bovine brain artery endothelial cells. Stroke 29, 844-849.
108. Sala-Rabanal M, Hirayama BA, Ghezzi C, Liu J, Huang S-C, Kepe V, Koepsell H, Yu A, Powell DR, Thorens B, Wright EM, Barrio JR (2016) Revisiting the physiology role of SGLTs and GLUTs using positron emission tomography in mice. J Physiol 594, 4425-4438.
109. +-D-glucose cotransporter SGLT1 in neurons. J Neurochem 69, 84-94.
110. Enerson BE, Drewes LR (2006) The rat blood-brain barrier transcriptome. J Cereb Blood Flow Metab 26, 959-973.
111. +/myo-inositol cotransporter. J Biol Chem 277, 35219-35224.
112. Michaelis T, Helms G, Merboldt KD, Hanicke W, Bruhn H, Frahm J (1993) Identification of Scyllo-inositol in proton NMR spectra of human brain in vivo. NMR Biomed 6, 105-109.
113. Chen J, Williams S, Ho S, Loraine H, Hagan D, Whaley JM, Feder JN (2010) Quantitative PCR tissue expression profiling of the humans SGLT2 gene and related family members. Diabetes Ther 1, 57-92.
114. Apparsundram S, Ferguson SM, Blackely RD (2001) Molecular cloning and characterization of a murine hemicholinum-3-sensitive choline transporter. Biochem Soc Trans 29, Pt6 711-716.
115. Hoyer S, Prem L, Sorbi S, Amsucci L (1993) Stimulation of glycolytic key enzymes in cerebral cortex by insulin. Neuroreport 4, 991-993.
116. van Houten M, Posner BI, Kopriwa BM, Brawer JR (1979) Insulin-binding sites in the rat brain: In vivo localization to the circumventrical organs by quantitative radioautography. Endocrinology 105, 666-673.
117. Unger J, McNeill TH, Moxley RT, 3rd, White M, Moss A, Livingston JN (1989) Distribution of insulin receptor-like immunoreactivity in the rat forebrain. Neuroscience 31, 143-157.
118. Biessels GJ, Bravenboer B, Gispen WH (2004) Glucose, insulin and the brain: A preface. Eur J Pharmacol 490, 1-4.
119. Banks WA (2004) The source of cerebral insulin. Eur J Pharmacol 490, 5-12.
120. Correia SC, Santos RX, Carvalho C, Cardoso S, Candeias E, Santos MS, Oliveira CR, Moreira PI (2012) Insulin signaling, glucose metabolism and mitochondria: Major palyers in Alzheimer's disease and diabetes interrelation. Brain Res 1441, 64-78.
121. Chen Y, Deng Y, Zhang B, Gong C-X (2014) Deregulation of brain insulin signaling in Alzheimer's disease. Neurosci Bull 30, 282-294.
122. de la Monte SM, Wands JR (2008) Alzheimer's disease is type 3 diabetes - evidence reviewed. J Diab Sci Technol 2, 1101-1113.
123. de la Monte SM, Tong M (2014) Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem Pharmacol 88, 548-559.
124. Steen E, Terry BM, Rivera EJ, Cannon JL, Neely TR, Tavares R, Xu XJ, Wands JR, de la Monte SM (2005) Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes? J Alzheimers Dis 7, 63-80.
125. Iqbal K, Grundke-Iqbal I (2005) Metabolic/signal transduction hypothesis of Alzheimer's disease and other tauopathies. Acta Neuropathol 109, 25-31.
126. Wang JZ, Liu F (2008) Microtubule associated protein tau in development, degeneration and protection of neurons. Prog Neurobiol 85, 148-175.
127. Lace GL, Wharton SB, Ince PG (2007) A brief history of tau: The evolving view of the microtubule-associated protein tau in neurodegenerative diseases. Clin Neuropathol 26, 43-58.
128. Hong M, Lee VM (1997) Insulin and insulin-like growth factor-1 regulate tau phosphorylation in cultured human neurons. J Biol Chem 272, 19547-19553.
129. Hoyer S, Lannert H (1999) Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats. Ann NY Acad Sci 893, 301-303.
130. Matioli MNPS, Nitrini R (2015) Mechanisms linking brain insulin resistance to Alzheimer's disease. Dement Neuropsychol 9, 96-102.
131. Selkoe DJ (2008) Biochemistry and molecular biology of amyloid beta-protein and the mechanism of Alzheimer's disease. Handb Clin Neurol 89, 245-260.
132. Selkoe DJ (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23-A31.
133. Cholerton B, Baker LD, Craft S (2011) Insulin resistance and pathological ageing. Diabet Med 28, 1463-1475.
134. Zhao L, Teter B, Morihara T, Lim GP, Ambeaokar SS, Ubeda OJ, Frautschy SA, Cole GM (2004) Insulindegrading enzyme as a downstream target of insulin signaling cascade: Implications for Alzheimer's disease intervention. J Neurosci 24, 11120-11126.
135. Talbot K, Wang H-Y, Kazi H, Han L-H, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE (2012) Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 122, 1316-1338.
136. Lee YJ, Kim JE, Hwang IS, Kwak MH, Lee JH, Jung YJ, An BS, Kwon HS, Kim BC, Kim SJ, Kim JM, Hwang DY (2013) Alzheimer's phenotypes induced by overexpression of human presenilin 2 mutant proteins stimulate significant changes in key factors of glucose metabolism. Mol Med Rep 7, 1571-1578.
137. Lizcano JM, Alessi DR (2002) The insulin signalling pathway. Curr Biol 12, R236-R238.
138. Sun A, Liu M, Nguyen XV, Bing G (2003) P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp Neurol 183, 394-405.
139. Schubert M, Gautman D, Surjo D, Ueki K, Baudler S, Schubert D, Kondo T, Alber J, Galldiks N, Küstermann E, Arndt S, Jacobs AH, Krone W, Kahn CR, Brüning JC (2004) Role for neuronal insulin resistance in neurodegenerative diseases. Proc Natl Acad Sci USA 101, 3100-3105.
140. Noble W, Planel E, Zehr C, Olm V, Meyerson J, Suleman F, Gaynor K, Wang L, La Francois J, Feinstein B, Burns M, Krishnamurthy P, Wen Y, Bhat R, Lewis J, Dickson D, Duff K (2005) Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci U S A 102, 6990-6995.
141. Munoz L, Ammit AJ (2015) Targeting p38 MAPK patchway for the treatment of Alzheimer's disease. Neuropharmacology 58, 561-568.
142. Kelleher I, Garwood C, Hanger DP, Anderton BH, Noble W (2007) Kinase activities increase during the development of tauopathy in htau mice. J Neurochem 103, 2256-2267.
143. Erickson MA, Banks WA (2013) Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease. J Cereb Blood Flow Metab 33, 1500-1513.
144. Keaney J, Campbell M (2015) The dynamic blood-brain barrier. FEBS J 282, 4067-4079.
145. Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J (2007) Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease. Psychiatry Res 155, 147-154.
146. Winkler EA, Nishida Y, Sagare AP, Rege SV, Bell RD, Perlmutter D, Sengillo JD, Hillman S, Kong P, Nelson AR, Sullivan JS, Zhao Z, Meiselman HJ, Wenby RB, Soto J, Abel ED, Makshanoff J, Zuniga E, De Vivo DC, Zlokovic BV (2015) GLUT1 reduction exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration. Nat Neurosci 18, 521-530.
147. Harik SI, Kalaria RN (1991) Blood-brain barriers abnormalities in Alzheimer's disease. Ann NY Acad Sci 640, 47-52.
148. Chen Z, Zhong C (2013) Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: Implications for diagnostic and therapeutic strategies. Prog Neurobiol 108, 21-43.
149. Zhong N, Weisgraber KH (2009) Understanding the association of apolipoprotein E4 with Alzheimer disease: Clues from its structure. J Biol Chem 284, 6027-6031.
150. de la Monte SM (2009) Insulin resistance and Alzheimer's disease. BMP Rep 42, 475-481.
151. Combs CK, Johnson DE, Karlo JC, Cannady SB, Landreth GE (2000) Inflammatory mechanisms in Alzheimer's disease: Inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. J Neurosci 20, 558-567.
152. Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, Fishel MA, Kulstad JJ, Green PS, Cook DG, Kahn SE, Keeling ML, Craft S (2005) Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone:Apreliminary study. Am J Geriatr Psychiatry 13, 950-958.
153. Pedersen WA, Flynn ER (2004) Insulin resistance contributes to aberrant stress responses in the Tg2576 mouse model of Alzheimer's disease. Neurobiol Dis 17, 500-506.
154. Kickstein E, Krauss S, Thornhill P, Rutschow D, Zeller R, Sharkey J, Williamson R, Fuchs M, Köhler A, Glossmann H, Schneider R, Sutherland C, Schweiger S (2010) Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proc Natl Acad Sci U S A 107, 21830-21835.
155. Hsu CC, Wahlqvist ML, Lee MS, Tsai HN (2011) Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin. J Alzheimers Dis 24, 485-493.
156. McClean PL, Parthsarathy V, Faivre E, Holscher C (2011) The diabetes drug liraglutide prevents neurodegenerative processess in a mouse model of Alzheimer's disease. J Neurosci 31, 6587-6594.
157. Blázquez E, Velázquez E, Hurtado-Carneiro V, Ruiz-Albusac JM (2014) Insulin in the brain: Its pathophysiological implications for states related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol 5, 161.
158. Vandal M, White PJ, Tremblay C, St-Amour I, Chevrier G, Emond V, Lefrançois D, Virgili J, Planel E, Giguere Y, Marette A, Calon F (2014) Insulin reverses the high-fat diet-induced increase in brain Aβ and improves memory in an animal model of Alzheimer disease. Diabetes 63, 4291-4301.
159. Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B (2012) Intranasal insulin therapy for Alzheimer's disease and amnestic mild cognitive impairment: A pilot clinical trial. Arch Neurol 69, 29-38.
160. Subramanian S, John M (2012) Intranasal administration of insulin lowers amyloid-beta levels in rat model of diabetes. Indian J Exp Biol 50, 41-44.
161. Yang Y, Ma D, Wang Y, Jiang T, Hu S, Zhang M, Yu X, Gong CX (2013) Intranasal insulin ameliorated tau hyperphosphorylation in a rat model of type 2 diabetes. J Alzheimers Dis 33, 329-338.
162. Rizvi SMD, Shakil S, Biswas D, Shakil S, Shaiks S, Bagga P, Kamal MA (2014) Invokana (Canagliflozin) as a dual inhibitor of acetylcholinesterase and sodium glucose co-transporter 2: Advancement in Alzheimer's diseasediabetes type 2 linkage via an enzoinformatics study. CNS Neurol Disord Drug Targ 13, 447-451.
163. Zeller K, Rahner-Welsch S, Kuschinsky W (1997) Distribution of Glut1 glucose transporters in different brain structure compared to glucose utilization and capillary density of adult rat brains. J Cereb Blood Flow Metab 17, 204-209.
164. Pearson-Leary J, McNay EC (2012) Intrahippocampal administration of amyloid-β1-42 oligomers impairs spatial working memory, insulin signaling, and hippocampal metabolism. J Alzheimers Dis 30, 413-422.
165. Chua LM, Lim ML, Chong PR, Hu ZP, Cheung NS, Wong BS (2012) Impaired neuronal insulin signaling precedes Aβ42 accumulation in female AβPPsw/PS1ΔE9 mice. J Alzheimers Dis 29, 783-791.